Mydecine Closes Sale of Mindleap for $3.6 million

Mydecine Closes Sale of Mindleap for .6 million
CANNANNEW REPORT

Starting this summer, we began reporting on the apparent troubles over at Mydecine. The company, once an underdog favorite with an interesting pipeline and clinical trial deals with Johns Hopkins, began a slow decline that caused many commentators to predict that the end was near. The majority of the board resigned, cash reserves dwindled to dangerous levels, and there was a […]

Excerpt only …
READ MORE BELOW
Source : Mydecine Closes Sale of Mindleap for .6 million

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.